Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty research firms that are currently covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $598.95.
A number of equities research analysts have recently commented on ISRG shares. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Finally, Royal Bank of Canada dropped their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd.
Read Our Latest Report on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
Institutional Trading of Intuitive Surgical
A number of large investors have recently made changes to their positions in the business. Bennett Selby Investments LP increased its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the last quarter. Onefund LLC boosted its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 18 shares during the period. AlphaCore Capital LLC boosted its stake in shares of Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock worth $235,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC boosted its stake in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Finally, Wesbanco Bank Inc. boosted its stake in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Up 0.4%
NASDAQ:ISRG opened at $563.95 on Wednesday. The company’s 50 day moving average price is $501.31 and its 200-day moving average price is $535.58. Intuitive Surgical has a 52 week low of $379.67 and a 52 week high of $616.00. The stock has a market cap of $202.13 billion, a price-to-earnings ratio of 87.98, a PEG ratio of 5.85 and a beta of 1.70.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the prior year, the company posted $1.50 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Investing in Travel Stocks Benefits
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Most Volatile Stocks, What Investors Need to Know
- Why Boeing May Be Ready to Take Off After Latest Developments
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.